Skip to main content

Bristol-Myers earnings beat fails to lift stock

Bristol-Myers Squibb Co. topped earnings expectations in the second quarter, but disappointing cancer trial results seemed to weigh on shares Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.